DDR1/2 enhance KIT activation and imatinib resistance of primary and secondary KIT mutants in gastrointestinal stromal tumors
暂无分享，去创建一个
Shaoting Zhang | Liangying Zhang | Sien Zhao | Anbu Liu | Xu Cao | Yuanyuan Yu | Zhaoyang Fan | Kun Xiao | Ming Wang | Ahmad Nasimian | Julhash U. Kazi | Shidong Xu | Shujing Li | Jinhai Tian | Hui Zhao | Lijun Ma | Jianmin Sun